BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $106 at Credit Suisse
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $66.70 -1.45%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $106.00 (from $105.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $59 at H.C. Wainwright
- Navios Maritime Partners (NMM) PT Raised to $100 at Jefferies
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
